Applied Materials vs. Amkor Technology: Which Artificial Intelligence Stock Is a Better Buy in 2026?

AI tailwinds are driving strong momentum in both Applied Materials and Amkor Technology, with AMAT posting 11% YoY sales growth to $7.9B in its fiscal Q2 and guiding semiconductor equipment growth to >30% in 2026. AMKR reported Q1 revenue up 27% YoY to $1.7B, with the market narrative calling for revenue rising to ~$11B by 2030. Despite value appeal (AMKR P/S 2.7x vs AMAT 17.0x; forward P/E 34.7x vs 49.5x) and resilient liquidity (current ratios ~2.6x and ~2.3x), the article flags key risks including AMAT’s $252M February 2026 export-violation settlement and AMKR’s customer concentration and in-house packaging substitution.

Analysis

The market mechanism here is less about “AI demand” and more about where the bottleneck sits in the stack. If advanced packaging stays constrained, value migrates upstream to the toolmakers and the platform controllers of capacity, not necessarily to the lowest-multiple OSATs; that favors AMAT and, second-order, TSM, while pure assembly/test names face margin leakage once capacity normalizes. A higher share of AI spend is likely to be captured by equipment and process-intellectual-property owners than by labor- and capex-heavy outsourced packagers.

The near-term risk is that investors pay for a multi-year packaging story before the financials prove it. Over the next 1-3 months, these names will trade more on revision momentum and AI capex sentiment than on realized earnings; over 6-18 months, the key question is whether packaging/test becomes a durable scarcity premium or a normal cyclical business again. AMAT’s bigger issue is policy: any China export tightening or enforcement action can compress the multiple fast, even if end-demand remains intact.

The contrarian miss is that “cheaper” may simply mean “lower-quality growth.” AMKR’s concentration and in-sourcing risk matter more in a downturn than the valuation gap suggests, while AMAT’s higher multiple can still be justified if AI packaging drives a longer capex runway and better FCF conversion. A relative-quality trade looks more attractive than an outright directional bet: long the cleaner cash generator and short the more execution-sensitive beneficiary unless AMKR shows a step-change in margin expansion and customer breadth.

Key Decisions for Investors

• Initiate a 3-6 month relative-value position: long AMAT / short AMKR on any strength in AMKR, targeting a re-rating toward quality and balance-sheet durability; thesis is wrong if AMKR sustains >15% revenue growth with expanding gross margin for 2 consecutive quarters.
• If adding AI-equipment exposure, prefer AMAT on pullbacks rather than chasing the packaging narrative; use a 5-8% drawdown entry zone as a better risk/reward point because the multiple is already carrying much of the growth story.
• Avoid a standalone long AMKR until there is clearer evidence on Arizona ramp execution and customer diversification; a slip in capex timing or CHIPS-related funding friction is the main catalyst to fade the name over the next 6-12 months.
• Use TSM as the cleaner upstream proxy for persistent advanced-packaging scarcity; if packaging bottlenecks remain tight into the next earnings cycle, TSM should preserve pricing power better than an OSAT and is less vulnerable to customer insourcing.
• Watch for any China/export-control headline on AMAT as a tactical hedge trigger; if policy risk re-accelerates, the best expression is to reduce AMAT beta exposure rather than sell the AI-packaging theme outright.